AwardedFinlandGoods€64,000
Hepcludex (bulevirtidi) -lääkevalmisteen valinta ajalle 1.4.2025-31.12.2025 Pohjois-Pohjanmaan hyvinvointialueen lääkehankintarenkaalle.
- Published
- Published 25 March 2025
Overview
Bulevirtidi-valmisteen suorahankinta. Suomen markkinoilla on vain yksi bulevirtidi-valmiste, joka on tarkoitettu hepatiitti deltaviruksen aiheuttaman infektion (HDV-infektion) hoitoon. Valitaan valmiste SPC:n mukaiseen käyttötarkoitukseen. Aikaisemmin D-hepatiitin parantavana hoitona on ollut vain maksansiirto. Tarjoushinta on kiinteä hankintakauden loppuun saakka. Sopimushinta perustuu HUS apteekin tekemään kansalliseen hintaneuvotteluun.
Key details
- Country
- Finland
- Status
- Awarded
- Category
- Goods
- Estimated value
- €64,000
- Procedure
- Direct
- Published
- 25 March 2025
Pharmaceutical products
Award outcome
- Awarded value
- €64,000
- Award date
- 14 April 2025
- Contract period
- 1 April 2025 → 31 December 2025
- Gilead Sciences Finland Oy
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
12 January 2026
Tender Update
25 March 2025
Contracting authority
Pohjois-Pohjanmaan hyvinvointialue
Procuring entityPOHDE, Finland
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.